Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
1.980
+0.060 (3.13%)
Dec 20, 2024, 4:00 PM EST - Market closed
LIXT Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -4 | -5.09 | -6.31 | -6.73 | -3.26 | -2.44 | |
| Stock-Based Compensation | 0.44 | 0.77 | 1.55 | 2.6 | 1.25 | 0.75 | |
| Change in Accounts Payable | -0.16 | -0.07 | 0 | 0.04 | 0.05 | -0.05 | |
| Change in Unearned Revenue | 0.17 | -0.01 | 0.09 | 0.06 | -0.08 | 0.08 | |
| Change in Other Net Operating Assets | 0.08 | 0.1 | 0.06 | -0.11 | -0.09 | -0.01 | |
| Operating Cash Flow | -3.47 | -4.29 | -4.61 | -4.14 | -2.13 | -1.67 | |
| Issuance of Common Stock | - | 3.14 | 5.14 | 3.91 | 5.7 | - | |
| Other Financing Activities | - | - | - | -0.01 | -1.1 | - | |
| Financing Cash Flow | - | 3.14 | 5.14 | 3.9 | 4.6 | - | |
| Net Cash Flow | -3.47 | -1.15 | 0.53 | -0.25 | 2.47 | -1.67 | |
| Free Cash Flow | -3.47 | -4.29 | -4.61 | -4.14 | -2.13 | -1.67 | |
| Free Cash Flow Per Share | -1.54 | -2.24 | -2.92 | -3.07 | -1.89 | -1.50 | |
| Cash Interest Paid | 0.02 | 0.02 | 0.01 | 0.01 | 0 | - | |
| Levered Free Cash Flow | -1.97 | -2.4 | -2.25 | -1.63 | -0.9 | -0.79 | |
| Unlevered Free Cash Flow | -1.95 | -2.39 | -2.24 | -1.63 | -0.9 | -0.79 | |
| Change in Net Working Capital | -0.09 | -0.02 | -0.15 | 0.02 | 0.11 | -0.02 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.